The electrical and structural properties of a nanocomposite material based on silver nanoparticles and graphene oxide were investigated. Using electron and atomic force microscopy it was shown that the nanoparticles formed predominantly have sizes from 60 to 100 nm. Measurements of the current-voltage characteristics showed electrical conductivity values significantly exceeding the parameters of the initial graphene oxide. The prepared nanocomposites were used for scanning by electron microscopy (SEM) of blood samples of sick children with hematuria syndrome and patients of the radiological department of an oncologic dispensary diagnosed with cervical cancer. The formation of nanosize objects on the surface of erythrocytes is revealed. The size of these volumes is comparable to the size of the viruses. Results of these studies can indirectly confirm an assumption of authors about possible transportation of viruses by erythrocytes to various organs and viral etiology of renal diseases with the hematuria syndrome and cervical cancer.
Introduction
To increase the contrast of images in the study of biological objects by electron microscopy, the surfaces of the materials under investigation are deposited by metals (Au, Pt, Ni, for example), which usually makes it difficult to study nanoscale particles.
Currently using a new class of electron microscopes to study the morphology of biological objects at low voltages and without metal deposition of the object [1] [2] [3] .
It is known, that the effects of a dielectric on the surface of the slide significantly
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PhysBioSymp17 degrade image quality due to the accumulation of electric charge. In this regard, for the study of red blood cells we have suggested a method of forming a nanostructured substrate with the use of the reduced graphene oxide (GO). Due to the fact, that the GO substrates contain oxygen groups, the total electrical conductivity of the system increases by their removal and introduction of silver (Ag) nanoparticles. Earlier, we proved that with the help of electron microscopy it becomes possible to reveal changes in the morphology of erythrocytes in pathology and is likely we can investigate the presences of biological particles (viruses) on the surface of red cell [1] [2] [3] .
The purpose of this study is development of methodology of formation of a nanostructured substrate of a composite of silver-graphene oxide for the study of changes in the morphology of erythrocytes by scanning electron microscopy in pathology.
Materials and methods
The GO suspension was obtained by graphite oxidation by a modified Hummers method [4] [5] [6] . To this end, a solution was prepared from 0.1 g of graphite powder, 0.05 g of sodium nitrate and concentrated sulfuric acid of 7 ml with the addition of 0.3 g of potassium permanganate. The solution was stirred for 4 weeks. After dilution with deionized water up to 25 ml, a solution of hydrogen peroxide (5%) was added to the mixture. The resulting yellow-yellow slurry was filtered to form a gel-like mass. The solution was then diluted with 50 ml of water and sonicated at 750 W for 5 min. The not exfoliated graphite oxide sheets were removed by centrifugation at 14500 rpm for 5 min. As a result, a homogeneous suspension of graphene oxide was obtained. To prepare the suspension with silver nanoparticles, aqueous solutions of sodium citrate (1 ml) and silver nitrate (0.25 ml) were successively added to 1.25 ml of water under constant stirring at room temperature. After 5 minutes of incubation and addition of boiling water, the color of the solution changes from colorless to cloudy brown. The resulting solution was additionally boiled for 1 hour with continuous stirring. Further, the solutions of silver nanoparticles and GO were mixed in volume ratio of 1:1. The prepared slurry was deposited on a Si substrate and dried at room temperature for 24 hours. Dielectric substrates were pre-washed in acetone and alcohol in an ultrasonic bath, to impart hydrophilic properties, were treated in an aqueous solution of hydrogen peroxide and ammonia. The resulting samples were partially reduced by treatment at a temperature of 523 K for 30 minutes in an argon atmosphere in order to reduce the content of oxygen functional groups in the GO.
Scanning electron microscopy ( JEOL JSM 7800F) with the integrated attachment of the X-ray energy dispersive spectrometer (EDS) (Inca Energy), atomic force microscopy (AFM) (Ntegra Spectra) and Raman spectroscopy (Ntegra Spectra) are used to characterize the nanocomposite properties. The electron microscope is equipped with a super-hybrid objective lens and the "Gentle Beam" system, which allows to obtain high-resolution images at low accelerating voltages, which is important for the study of biological objects. The use of such systems makes it possible to obtain images of the erythrocyte surface without the deposition of electrically conductive coatings. Accelerating voltages of 6 kV and 1 kV, respectively, were used to study silver nanoparticles and blood smears. The current-voltage characteristics were measured by the fourprobe Van der Pau method (Ecopia 5500 HMS). the presence of defects for activation. The overtone D peak (2D peak) is observed at 2700 cm −1 and is caused by a double resonance transition [7] [8] [9] [10] . This peak, unlike the D band, is observed even in the absence of defects. The band D+G at ∼2930 cm −1 is also activated by defects. The ratio of the intensities of the D-and G-bands is widely used to characterize crystal disorder and defects in graphene-based materials [11, 12] .
Results and discussion
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This ratio is 0.94 and 0.90 for the nanocomposite and GO respectively. It follows from this that when the rGO-Ag nanocomposite is formed, an insignificant increase in the defectiveness of the structure of the GO occurs. to both an increase in the concentration of charge carriers [13] and a modification of the mechanism of charge carrier transport [14, 15] .
The obtained rGO-Ag composite was used to study the viral etiological factor of nephropathies with hematuria syndrome. The presence of such nanoobjects on the surface of erythrocytes was observed in patients with diseases of Berger and other types of nephropathy [2, 3] , as well as for patients with cervical cancer. Figure 5 shows images of the surface of a red blood cell sample of a girl of 10 years with chronic glomerulonephritis at magnifications of 50,000× on a substrate of glass. Also on the glass substrate the image of the surface of a red blood sample of a patient 47 years old obtained which has diagnosis of cancer of the cervix at a magnification of 20,000× ( Figure 6 ). possible to more accurately reveal the shape and size of these objects (Figure 7-9 ).
Improving the image quality of objects can be due to the elimination of accumulation of charges on the surface of dielectric materials (glass) under electron irradiation in SEM. Thus, the use of rGO-Ag nanocomposite substrates should improve the quality of diagnosing difficult types of nephropathy. 
Conclusion
From the studies of electrical characteristics, it has been established that the synthesized rGO-Ag nanocomposite exhibits higher values of electrical conductivity than the pristine partially reduced samples of GO The use of substrates from this composite material allows more accurately reveal the shapes and sizes of biological nanoparticles.
Improving the image quality of objects can also be due to the elimination of effects associated with the accumulation of dielectric materials (glass) on the surface under electron irradiation in SEM. Thus, nanocomposite rGO-Ag was used as a substrate for the study of blood smears, which were taken from patients with revealed signs of macrohematuria, by the SEM method. Nanosize particles on the surface of erythrocyte were observed, the sizes of which are comparable to the sizes of the viruses. The results of the work are of interest for the formation of a non-invasive differential complex method for the study of difficult to diagnose types of nephropathies, as well as a method for monitoring radiation therapy for cervical cancer.
